Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Assets:
Cash and cash equivalents	$ 6	$ 78
Other assets	0	0
Total assets	6	78
Liabilities:
Accounts payable and accrued liabilities	4,642	3,225
Loan(s) payable - related party	3,548	3,198
Total liabilities	8,190	6,423
Commitments and contingencies (Note 6)
Stockholders' equity (deficit):
Common stock ($0.01 par value, 85,000 authorized in 2024 and 85,000 authorized in 2023, 46,410 issued and 40,738 outstanding in 2024 and 46,410 issued and 40,738 outstanding in 2023)	464	464
Additional paid-in capital	548,304	548,304
Accumulated deficit	(551,784)	(549,945)
Treasury stock, at cost - 2024 - 5,672 shares; and 2023 - 5,672 shares	(5,168)	(5,168)
Total stockholders' equity (deficit)	(8,184)	(6,345)
Total liabilities and stockholders' equity (deficit)	$ 6	$ 78